Effect of vitamin D supplementation versus placebo on recovery delay among COVID-19 Tunisian patients: a randomized-controlled clinical trial
ConclusionVDs was not associated with a shortened recovery delay when given to patients for whom the RT-PCR remained positive on the 14th day.Trial registrationThis study was approved by the Human Subjects Protection Tunisia center (TN2020-NAT-INS-40) on April 28, 2020, and by ClinicalTrial.gov on May 12, 2021 with approval number ClinicalTrials.gov ID:NCT04883203.
Source: Trials - Category: Research Source Type: clinical trials
More News: Clinical Trials | Coronavirus | COVID-19 | Research | Respiratory Medicine | SARS | Study | Tunisia Health | Vitamin D | Vitamin D3 | Vitamins